Novozymes A/S (CPH:NSIS.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
403.90
+3.30 (0.82%)
At close: Dec 5, 2025

Novozymes Revenue

Novozymes had revenue of 1.06B EUR in the quarter ending September 30, 2025, with 8.86% growth. This brings the company's revenue in the last twelve months to 4.14B, up 19.33% year-over-year. In the year 2024, Novozymes had annual revenue of 3.83B with 59.58% growth.

Revenue (ttm)
4.14B EUR
Revenue Growth
+19.33%
P/S Ratio
6.08
Revenue / Employee
391.46K EUR
Employees
10,582
Market Cap
188.05B DKK

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.83B1.43B59.58%
Dec 31, 20232.40B42.38M1.80%
Dec 31, 20222.36B348.99M17.36%
Dec 31, 20212.01B128.32M6.82%
Dec 31, 20201.88B-41.10M-2.14%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SP Group 2.85B
H+H International 2.78B
Flügger group 2.27B
Scandinavian Investment Group 25.10M
RIAS A/S 320.36M
Hove A/S 204.35M
Revenue Rankings